Showing results (861-870 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|April 25, 2009
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcomaSteven G DuBois, Holcombe E GrierNature Reviews. Clinical Oncology|April 25, 2009
Hematology: Bortezomib in newly diagnosed multiple myelomaJames R BerensonNature Reviews. Clinical Oncology|August 19, 2009
Role of cancer stem cells in pancreatic ductal adenocarcinomaGregory Sergeant, Hugo Vankelecom, Lies Gremeaux, et al.Nature Reviews. Clinical Oncology|July 29, 2009
Targeting angiogenesis: progress with anti-VEGF treatment with large moleculesAxel Grothey, Evanthia GalanisNature Reviews. Clinical Oncology|August 27, 2009
Controlling the cost of innovative cancer therapeuticsNafees N MalikNature Reviews. Clinical Oncology|July 8, 2009
Adverse effects of anticancer agents that target the VEGF pathwayHelen X Chen, Jessica N CleckNature Reviews. Clinical Oncology|July 8, 2009
Systems pathology--taking molecular pathology into a new dimensionDana Faratian, Robert G Clyde, John W Crawford, et al.Nature Reviews. Clinical Oncology|September 9, 2009
An overview of small-molecule inhibitors of VEGFR signalingS Percy Ivy, Jeannette Y Wick, Bennett M KaufmanNature Reviews. Clinical Oncology|September 30, 2010
Triple-negative breast cancer: disease entity or title of convenience?Lisa Carey, Eric Winer, Giuseppe Viale, et al.Nature Reviews. Clinical Oncology|August 12, 2010
Making the best of PARP inhibitors in ovarian cancerSusana Banerjee, Stan B Kaye, Alan AshworthPageof 97